Mal-Gly-PAB-Exatecan-D-glucuronic acid 适用于抗体药物偶联物 (ADC) 的合成，并在肿瘤研究及诊断领域有研究应用。

DBCO-PEG3-VC-Exatecan (compound 25) 作为一种ADC药物-连接子偶联物 (Drug-Linker Conjugate for ADC)，由具有抑制DNA拓扑异构酶I (topoisomerase I) 功能的Exatecan以及ADC连结子 (DBCO-PEG3-VC) 组成。

APL-1081 (Mal-Exo-EVC-MMAE) 屬於抗体偶联活性分子ADC中的一个组成部分。此化合物由ADC linker(peptide Mal-Exo-EEVC) 与强效的微管蛋白聚合抑制剂MMAE通过偶联生成。

SPDB-DM4 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications, employing the maytansine-based payload DM4 (a tubulin inhibitor) connected through a SPDB linker. This compound demonstrates significant anti-tumor efficacy.

Mipsagargin (G-202) 是一种抑制 DNA 生物合成的新型抗生素。

MC-Val-Cit-PAB-rifabutin is a drug-linker conjugate designed for antibody-drug conjugates (ADC), featuring the potent antitumor agent rifabutin (a DNA-dependent RNA polymerase inhibitor) connected through the MC-Val-Cit-PAB ADC linker. This configuration endows it with significant antitumor activity.